Vancouver BC-based
Mind Cure Health Inc. (MINDCURE) (
CSE.MCUR,
OTCMQX: MCURF,
Forum) had announced today that a special committee of the Company's board of directors (the Special Committee) has concluded the initial phases of its previously announced strategic review process.
The Chair of MINDCURE's Special Committee, Jason Pamer, commented:
"Though we continue the Strategic Review Process, we have identified no available strategic alternatives that would require further development and execution of MINDCURE's existing business plan. As a result, we have determined that the Company should immediately move to reduce all non-necessary expenditures except as required to preserve the value of the Company's cash balance and other assets."
Full news release
here.
About Mind Cure Health Inc.
MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health. The company is focused on the development, manufacture, and distribution of a branded line of organic, functional mushroom extracts. Its products are marketed under the Moonbeam Brand.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.
FULL DISCLOSURE: Mind Cure Health Inc. is a client of Stockhouse Publishing.